Position in DHR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$21,333
+$98 QoQ
Shares Held
112
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,950
of 2,098 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $416,407 across 8 Diagnostics & Research names. DHR ranks #3 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
715 | $358,472 | |
| 2 | A |
Agilent Technologies, Inc.
|
180 | $23,909 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
112 | $21,333 | |
| 4 | RVTY |
Revvity, Inc.
|
100 | $11,126 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1 | $526 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
2 | $386 | |
| 7 | WAT |
Waters Corp /De/
|
1 | $375 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1 | $280 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,333 | 112 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $21,235 | 112 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $25,639 | 112 | Shares | Sole | 2026-01-27 | |
| 2022-09-30 | $977,111 | 3,783 | Shares | Sole | 2022-10-06 | |
| 2022-03-31 | $1,860,885 | 6,344 | Shares | Sole | 2022-04-20 | |
| 2021-09-30 | $1,934,107 | 6,353 | Shares | Sole | 2021-10-07 | |
| 2021-03-31 | $1,043,470 | 4,636 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $888,782 | 4,001 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $737,074 | 3,423 | Shares | Sole | 2020-11-27 | |
| 2020-06-30 | $667,533 | 3,775 | Shares | Sole | 2020-09-11 | |
| No filing history on record for this holder in this stock. | ||||||